Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Bel-Mar is a Mexican pharmaceutical company founded in 1954, specializing in the development, manufacture, and distribution of a wide range of medicinal products. The company's portfolio includes antibiotics, analgesics, anti-inflammatories, and treatments for respiratory and gastrointestinal conditions, primarily in small molecule formats. Laboratorios Bel-Mar operates manufacturing facilities that adhere to Good Manufacturing Practices (GMP) and provides contract manufacturing services (CMO) to other pharmaceutical entities. With a strong presence in the Mexican healthcare market, the company focuses on delivering accessible and effective therapeutic solutions to patients and healthcare providers. Its long-standing reputation is built on quality manufacturing and a diverse product line that serves both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bel Mar.